Product Categories
| Country: | United States |
|---|---|
| Tel: | +1-781-999-5354 |
| Mobile: | +17819995354 |
| E-mail: | marketing@targetmol.com |
| QQ: | |
| Skype: | Chat Now! |
| Address: | 36?Washington?Street, Wellesley?Hills |
|
Target Molecule Corp. (TargetMol) is a global high-tech enterprise, headquartered in Boston, MA, specializing in chemical and biological research product and service to meet the research needs of global customers.
TargetMol has evolved into one of the biggest global compound library and small molecule suppliers and a customer based on 40+ countries. TargetMol offers over 80 types of compound libraries and a wide range of high-quality research chemicals including inhibitors, activator, natural compounds, peptides, inhibitory antibodies, and novel life-science kits, for laboratory and scientific use. Besides, virtual screening service is also available for customers who would like to conduct the computer-aided drug discovery.
|
|
| Product Name | MF | CAS | Details |
|---|
| trans-Doxercalciferol | C28H44O2 | 74007-20-8 | Details |
| Triacsin C；FR 900190;WS 1228A | C11H17N3O | 76896-80-5 | Details |
| Triamcinolone Benetonide | C35H42FNO8 | 31002-79-6 | Details |
| Disopyramide | C21H29N3O | 3737-09-5 | Details |
| Trilaciclib hydrochloride | C24H31ClN8O | 1977495-97-8 | Details |
| TRPC6-IN-1 | C21H23FN4O3 | 901715-05-7 | Details |
| TrkA-IN-1 | C25H20N4O | 1680179-43-4 | Details |
| Tromantadine hydrochloride | C16H28N2O2.ClH | 41544-24-5 | Details |
| Tromantadine | C16H28N2O2 | 53783-83-8 | Details |
| Trimetazidine-N-oxide | C14H22N2O4 | 1644530-89-1 | Details |
| Triphala | W99 | 857906-76-4 | Details |
| Tris(2,4-di-tert-butylphenyl)phosphate | C42H63O4P | 95906-11-9 | Details |
| Tropodifene；Tropaphen | C25H29NO4 | 15790-02-0 | Details |
| Nonivamide | C17H27NO3 | 2444-46-4 | Details |
| Trombodipine | C21H24N2O7S | 113658-85-8 | Details |
| PF-06733804 | C20H19F5N4O4 | 1873373-33-1 | Details |
| TRPV4 agonist-1 | C25H23ClF2N4O2 | 2314467-60-0 | Details |
| TRPA1 Antagonist 1 | C24H23F6N5NaO7PS | 1984825-08-2 | Details |
| Tubulin inhibitor 7 | C21H14N2O4 | 1309925-41-4 | Details |
| TTA-Q6(isomer) | C20H15ClF3N3O | 910484-32-1 | Details |
| TTP-8307 | C27H21FN4O | 950225-08-8 | Details |
| TTT-28 | C31H31N3O6S | 1609138-51-3 | Details |
| Tuberculosis inhibitor 1 | C34H37N5O3 | 2230810-28-1 | Details |
| Tubulin inhibitor 6 | C20H14ClNO2S | 105925-39-1 | Details |
| TT-OAD2 | C50H48Cl3N3O6 | 2382719-60-8 | Details |
| Bendazol | C14H12N2 | 621-72-7 | Details |
| N-(3-Chloro-4-morpholinophenyl)-N'-hydroxyformimidamide；TS-011 | C11H14ClN3O2 | 339071-18-0 | Details |
| TSHR antagonist S37 | C25H20N2O3S2 | 1217616-61-9 | Details |
| TSHR antagonist S37a | C25H20N2O3S2 | 2143452-20-2 | Details |
| TXNIP-IN-1 | C12H12N2O4 | 1268955-50-5 | Details |
| Artemether | C16H26O5 | 71963-77-4 | Details |
| Tubulin inhibitor 1 | C21H24N2O4 | 2237054-53-2 | Details |
| Trovafloxacin mesylate | C21H19F3N4O6S | 147059-75-4 | Details |
| Tubulysin D | C43H65N5O9S | 309935-57-7 | Details |
| Tunicamycin | C37H60N4O16 | 11089-65-9 | Details |
| Tubulin inhibitor 8 | C21H14N2O3 | 1309925-39-0 | Details |
| UbcH5c-IN-1 | C22H21BrO3 | 2123480-72-6 | Details |
| UK-370106 | C35H44N2O5 | 230961-21-4 | Details |
| Umibecestat | C19H15ClF7N5O2 | 1387560-01-1 | Details |
| UKI-1；UKI-1C | C32H47N5O5S | 220355-63-5 | Details |
| Upamostat | C32H47N5O6S | 590368-25-5 | Details |
| Trovafloxacin | C20H15F3N4O3 | 147059-72-1 | Details |
| UK-240455 | C11H11Cl2N3O5S | 178908-09-3 | Details |
| UK51656 | C22H28ClN3O6 | 88150-59-8 | Details |
| UCSF924 | C20H22N2O2 | 1434515-70-4 | Details |
| Ubiquinol；CoQH2-10;Ubiquinol-10 | C59H92O4 | 992-78-9 | Details |
| T 82 | C30H33N3O6 | 252264-92-9 | Details |
| U91356 | C13H17N3O | 152886-85-6 | Details |
| O-Phospho-L-serine | C3H8NO6P | 407-41-0 | Details |
| Tyk2-IN-7 | C18H18N6O3S | 1609391-90-3 | Details |
| Oliceridine hydrochloride；TRV130 (hydrochloride) | C22H31ClN2O2S | 1401031-39-7 | Details |
| Tyk2-IN-9 | C20H17N9 | 2127109-85-5 | Details |
| Oliceridine (Racemate)；TRV130 (Racemate) | C22H30N2O2S | 1401028-25-8 | Details |
| Tyrphostin AG1433 | C16H14N2O2 | 168835-90-3 | Details |
| Tyk2-IN-5 | C21H19FN8O2 | 1797432-62-2 | Details |
| Tyk2-IN-3 | C25H24N6O3S2 | 1779493-12-7 | Details |
| TyK2-IN-2 | C16H18N6O | 2098466-94-3 | Details |
| UNC10217938A | C26H28N6O2 | 1347749-97-6 | Details |
| UP202-56 | C33H37N7O4 | 163838-04-8 | Details |
| Ubiquitination-IN-1 | C21H14F3N3O2S | 1819330-15-8 | Details |
| UK-101 | C25H48N2O5Si | 1000313-40-5 | Details |
| Carprofen | C15H12ClNO2 | 53716-49-7 | Details |
| UCT943 | C22H20F3N5O | 1450666-80-4 | Details |
| (S)-Rasagiline mesylate；TVP1022 (mesylate);S-PAI mesylate | C13H17NO3S | 202464-88-8 | Details |
| (S)-Rasagiline；TVP1022;S-PAI | C12H13N | 185517-74-2 | Details |
| UPF-648 sodium salt | C11H9Cl2NaO3 | 1465017-87-1 | Details |
| TTA-Q6 | C20H15ClF3N3O | 910484-28-5 | Details |
| Uridine 5'-diphosphate sodium salt | C9H12N2Na2O12P2 | 21931-53-3 | Details |
| FCE 28654 | C25H35N2O7P | 169474-77-5 | Details |
| COX/5-LO-IN-1；Atreleuton analog | C16H15FN2O2S | 154355-75-6 | Details |
| Gentamicin sulfate | C60H127N15O26S | 1405-41-0 | Details |
| CCK-B Receptor Antagonist 1 | C28H30N6O3 | 168161-71-5 | Details |
| Gastrin/CCK antagonist 1 | C28H32FN5O4 | 162271-52-5 | Details |
| EHP-101 | C28H35NO3 | 1818428-24-8 | Details |
| URAT1 inhibitor 1 | C19H15Br2N5O2S2 | 2268720-62-1 | Details |
| Valsartan Ethyl Ester | C26H33N5O3 | 1111177-30-0 | Details |
| Usaramine N-oxide | C18H25NO7 | 117020-54-9 | Details |
| VAF347 | C17H11ClF3N3 | 574759-62-9 | Details |
| DL-trihexyphenidyl hydrochloride | C20H32ClNO | 58947-95-8 | Details |
| Vabicaserin hydrochloride | C15H21ClN2 | 887258-94-8 | Details |
| Vapendavir diphosphate；BTA798 diphosphate | C21H29N4O7P | 1198151-75-5 | Details |
| VBY-825 | C23H29F4N3O5S | 1310340-58-9 | Details |
| VBIT-4 | C21H23ClF3N3O3 | 2086257-77-2 | Details |
| Valategrast；R-411 free base | C30H32Cl3N3O4 | 220847-86-9 | Details |
| Valemetostat tosylate；DS-3201 tosylate | C33H42ClN3O7S | 1809336-93-3 | Details |
| USP7-IN-3 | C29H31F3N6O3 | 2202738-42-7 | Details |
| USP7-IN-5 | C36H43N5O6 | 2166599-74-0 | Details |
| USP7-IN-6 | C41H43N7O4S | 2166586-47-4 | Details |
| UT-155 | C20H15F4N3O2 | 2031161-35-8 | Details |
| USP7-IN-1 | C23H24ClN3O3 | 1381291-36-6 | Details |
| Nortriptyline hydrochloride | C19H22ClN | 894-71-3 | Details |
| Urolithin B | C13H8O3 | 1139-83-9 | Details |
| USP30 inhibitor 11 | C17H16N6O2S | 2067332-64-1 | Details |
| Valecobulin hydrochloride | C26H29ClN6O5S | 1240321-53-2 | Details |
| UT-34 | C15H12F4N4O2 | 2168525-92-4 | Details |
| Utibapril；FPL 63547 | C22H31N3O5S | 109683-61-6 | Details |
| Valopicitabine；NM283 | C15H24N4O6 | 640281-90-9 | Details |
| Valerylcarnitine | C12H23NO4 | 40225-14-7 | Details |
| Valsartan-d9；CGP-48933 D9;Valsartan D9 | C24H29N5O3 | 1089736-73-1 | Details |
| Vatinoxan hydrochloride；MK-467 hydrochloride;L-659066 hydrochloride | C20H27ClN4O4S | 130466-38-5 | Details |
| Product Total： Product Page： | ||||
| 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64 65 66 67 68 69 70 71 72 73 74 75 76 77 78 79 80 81 82 83 84 85 86 87 88 89 90 91 92 93 94 95 96 97 98 99 100 101 102 103 104 105 106 107 108 109 110 111 112 113 114 115 116 117 118 119 120 121 122 123 124 125 126 127 128 129 130 131 132 133 134 135 136 137 138 139 140 141 142 143 144 145 | ||||